Article
ICOS gene polymorphisms in B-cell chronic lymphocytic leukemia in the Polish population.
Folia histochemica et cytobiologica - 1 Jan 2011
Karabon Lidia, Jedynak Anna, Tomkiewicz Anna, Wolowiec Dariusz, Kielbinski Marek, Woszczyk Dariusz, Kuliczkowski Kazimierz, Frydecka Irena
Abstract excerpt
There is strong evidence that altered immunological function entails an increased risk of B-cell chronic lymphocytic leukemia (B-CLL). The main mechanism of an anti-tumor response depends on T-cell activation. Unlike the constitutively expressed CD28, inducible costimulatory molecule (ICOS) is expressed on the T-cell surface after activation. ICOS enhances all the basic T-cell responses to a foreign antigen,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
